Coping with Cannabis During Pregnancy: Trajectories of Depression, Stress, and Cannabis Use across the Prenatal Period
Constantino-Pettit, A.; Tillman, R.; Wilson, J.; Lashley-Simms, N.; Vatan, N.; Atkinson, A.; Leverett, S. D.; Lenze, S.; Smyser, C.; Bogdan, R.; Rogers, C.; Agrawal, A.
Show abstract
ObjectiveWe examined trajectories of stress, depression, and cannabis use across the prenatal period. We also investigated whether individuals who reported using cannabis to alleviate stress and depressive symptoms experienced symptom relief across the prenatal period. MethodsPregnant individuals (n=436) with a history of lifetime cannabis use were recruited and identified either as prenatal cannabis users (PCU; continued cannabis use following knowledge of pregnancy in the first trimester) or non-prenatal cannabis users (NPCU; no cannabis use following knowledge of pregnancy in the first trimester). PCU individuals additionally reported on reasons for continued cannabis use during pregnancy. We employed longitudinal multivariate modeling to examine trajectories of depression (maternal self-report; Edinburgh Postnatal Depression Scale), stress (maternal self-report; Perceived Stress Scale), and cannabis use (maternal self-report and urinalysis) over time, stratified by motives for use during the perinatal period. ResultsStress, depression, and cannabis use decreased from the first to the third trimester (slope B= -0.21, -0.35, and -0.31, respectively). While cannabis use and depression at the first trimester were correlated with one another, they did not affect the others rate of change. Cannabis use similarly did not affect the rate of change in stress. Finally, while individuals using cannabis to cope with mental health symptoms experienced a decrease in overall depression symptoms, this slope was roughly equivalent to individuals who were not using cannabis prenatally (slope B= - 0.43 and -0.51, respectively). ConclusionOur sample experienced a collective decrease in depression, stress, and cannabis use prenatally. This decline in cannabis use - even among those who reported using to cope with mental health conditions - was not attributable to the decrease in depressive symptoms. This study lends valuable insight into the reasons why individuals continue to use cannabis during pregnancy, which providers can use to help tailor recommendations for other sources of coping and support to childbearing individuals.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of First Episode Psychosis patients and controls 95%
- The Positive End of the Polygenic Score Distribution for ADHD: A Low Risk or a Protective Factor? 91%
- Anorexia nervosa polygenic risk, beyond diagnoses: relationship with adolescent disordered eating and behaviours in an Australian female twin population 91%
Similar papers in this journal
- Sex and Gender Influences on Problematic Cannabis Use and Cannabis Use Disorder: A Scoping Review Protocol 95%
- Trace amine-associated receptor gene polymorphism increases drug craving 93%
- Emotion regulation and cognitive function as mediating factors for the association between lifetime abuse and risky behaviors in women of color 93%
Similar papers in this journal
Similar papers in this journal
- Systematic Review and Meta-Analysis of the Effect of Adverse Childhood Experiences (ACEs) on Brain-Derived Neurotrophic Factor (BDNF) Levels 93%
- Changes in affect variability after starting gender-affirming hormone therapy 93%
- Reduced threat avoidance but increased stress induced approach bias in women taking oral contraceptives 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.